510(k) K233391

cCeLL - In vivo by VPIX Medical, Inc. — Product Code GWG

K233391 is an FDA 510(k) premarket notification submitted by VPIX Medical, Inc. for the device "cCeLL - In vivo". The FDA issued a decision of Substantially Equivalent on Aug 21, 2024. The device falls under product code GWG (Endoscope, Neurological), a Class II device regulated under 21 CFR 882.1480. VPIX Medical, Inc. has 3 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Aug 21, 2024
Date Received
Oct 2, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Endoscope, Neurological
Device Class
Class II
Regulation Number
882.1480
Review Panel
NE
Submission Type
510(k)

If the device is reusable, validated reprocessing instructions and reprocessing validation data for this device type must be included in a 510(k) submission (82 FR 26807, available at https://www.gpo.gov/fdsys/pkg/FR-2017-06-09/pdf/2017-12007.pdf).

Need the full FDA record for VPIX Medical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K233391. Report a data issue: hello@regdatalab.com.